Dec 4, 20241 min read

Breakthrough Research Promises Shorter Treatment for Multi-Drug-Resistant TB

The positive EndTB-Q trial results were shared at the Union conference. They showed

that a BCDL regimen is successful in treating less severe MDR TB in 6-9 months, when

compared to the longer WHO regimen. The longer WHO regimen still remains more

successful in severe cases. Read more here.

Recent Posts

The results of the TB-CHAMP trial were recently published. They showed that prophylactic levofloxacin can significantly reduce the risk...

This month, the Indian Patent Office denied the last of the three Janssen patent extension applications for bedaquiline. While TB...

The Institute of Tropical Medicine has announced two initiatives to honor the legacy of Armand Van Deun: a new meeting room in his name...